ABL1 and acute lymphoblastic leukemia: In the field of ALL research, the first application of third-generation sequencing technology led to the detection of BCR-ABL1 KD mutations in Ph-positive leukemia patients, revealing higher sensitivity and specificity than Sanger sequencing [16].